Hourly Market Review - Nov 18, 2024 9 AM

Market BriefMonday, Nov 18, 2024 10:00 am ET

1min read

Movers of the hour:

Aclaris Therapeutics is up 36.58% at $2.80.

Fate Therapeutics is up 34.12% at $2.71.

Super Micro Computer is up 19.08% at $22.13.

Regenxbio is up 16.30% at $11.20.

Destiny Tech100 is up 16.16% at $37.39.

Here are the top stocks upgraded by Wall Street analyst:

Apple has received a rating of Strong Buy from Needham with target price increased to $260 from $260.

Apple has received a rating of Strong Buy from Rosenblatt with target price increased to $262 from $261.

Apple has received a rating of Sell from Barclays with target price dropped to $184 from $186.

Apple has received a rating of Neutral from Maxim Group with target price increased to $215 from $203.

Nvidia has received a rating of Buy from Oppenheimer with target price increased to $175 from $150.

Nvidia has received a rating of Strong Buy from HSBC with target price increased to $200 from $145.

Nvidia has received a rating of Strong Buy from Susquehanna with target price increased to $180 from $160.

Nvidia has received a rating of Strong Buy from Raymond James with target price increased to $170 from $140.

Nvidia has received a rating of Buy from Wedbush with target price increased to $160 from $138.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.